Literature DB >> 21116843

Modifiable risk factors for prostate cancer mortality in London: forty years of follow-up in the Whitehall study.

G David Batty1, Mika Kivimäki, Robert Clarke, George Davey Smith, Martin J Shipley.   

Abstract

BACKGROUND: The determinants of prostate cancer--aside from established but non-modifiable risk factors of increased age, black ethnicity, and a positive family history--are poorly understood.
METHODS: We examined the association of a series of baseline socioeconomic, behavioral, and metabolic characteristics with the risk of prostate cancer mortality in a 40-year follow-up of study members from the original Whitehall cohort study. During this period there were 578 prostate cancer deaths in 17,934 men.
RESULTS: After adjustment for a series of baseline covariates, results from proportional hazards regression analyses indicated that marital status (hazard ratio; 95% confidence interval: widowed/divorced vs. married: 1.44; 0.95, 2.18), raised blood cholesterol (tertile 3 vs. 1: 1.35; 1.11, 1.65), and increased physical stature (tertile 3 vs. 1: 1.37; 1.09, 1.74) were associated with death from prostate cancer, although statistical significance at conventional levels was not apparent in all analyses. There was no evidence that physical activity, smoking habit, socio-economic status, component of either blood pressure or diabetes predicted the risk of death from this malignancy herein.
CONCLUSIONS: In the present study, there was a suggestion that marital status, blood cholesterol, and height were risk indices for death from prostate cancer.

Entities:  

Mesh:

Year:  2010        PMID: 21116843      PMCID: PMC3226949          DOI: 10.1007/s10552-010-9691-6

Source DB:  PubMed          Journal:  Cancer Causes Control        ISSN: 0957-5243            Impact factor:   2.506


  35 in total

Review 1.  Smoking and prostate cancer.

Authors:  K Hickey; K A Do; A Green
Journal:  Epidemiol Rev       Date:  2001       Impact factor: 6.222

2.  Men with low serum cholesterol have a lower risk of high-grade prostate cancer in the placebo arm of the prostate cancer prevention trial.

Authors:  Elizabeth A Platz; Cathee Till; Phyllis J Goodman; Howard L Parnes; William D Figg; Demetrius Albanes; Marian L Neuhouser; Eric A Klein; Ian M Thompson; Alan R Kristal
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-11-03       Impact factor: 4.254

3.  Association of low plasma cholesterol with mortality for cancer at various sites in men: 17-y follow-up of the prospective Basel study.

Authors:  M Eichholzer; H B Stähelin; F Gutzwiller; E Lüdin; F Bernasconi
Journal:  Am J Clin Nutr       Date:  2000-02       Impact factor: 7.045

4.  Height and risk of death among men and women: aetiological implications of associations with cardiorespiratory disease and cancer mortality.

Authors:  G Davey Smith; C Hart; M Upton; D Hole; C Gillis; G Watt; V Hawthorne
Journal:  J Epidemiol Community Health       Date:  2000-02       Impact factor: 3.710

Review 5.  Height, wealth, and health: an overview with new data from three longitudinal studies.

Authors:  G David Batty; Martin J Shipley; David Gunnell; Rachel Huxley; Mika Kivimaki; Mark Woodward; Crystal Man Ying Lee; George Davey Smith
Journal:  Econ Hum Biol       Date:  2009-06-28       Impact factor: 2.184

6.  The impact of modifiable risk factors on mortality from prostate cancer in populations of the Asia-Pacific region.

Authors:  Rachel Huxley; A Ansary-Mohaddam; R Huxley; F Barzi; T H Lam; K Jamrozik; T Ohkubo; X Fang; H J Sun; M Woodward; D F Gu; A Rodgers; Y Imai; W H Pan; I Suh; H J Sun; H Ueshima
Journal:  Asian Pac J Cancer Prev       Date:  2007 Apr-Jun

7.  Association between plasma cholesterol and prostate cancer in the PSA era.

Authors:  Elizabeth A Platz; Steven K Clinton; Edward Giovannucci
Journal:  Int J Cancer       Date:  2008-10-01       Impact factor: 7.396

8.  Association between plasma total cholesterol concentration and incident prostate cancer in the CLUE II cohort.

Authors:  Alison M Mondul; Sandra L Clipp; Kathy J Helzlsouer; Elizabeth A Platz
Journal:  Cancer Causes Control       Date:  2009-10-06       Impact factor: 2.506

9.  Physical activity and cause-specific mortality in the Whitehall study.

Authors:  G Davey Smith; M J Shipley; G D Batty; J N Morris; M Marmot
Journal:  Public Health       Date:  2000-09       Impact factor: 2.427

10.  Adult height and lung function as markers of life course exposures: associations with risk factors and cause-specific mortality.

Authors:  G David Batty; David Gunnell; Claudia Langenberg; George Davey Smith; Michael G Marmot; Martin J Shipley
Journal:  Eur J Epidemiol       Date:  2006-11-22       Impact factor: 8.082

View more
  32 in total

Review 1.  Potential for prostate cancer prevention through physical activity.

Authors:  Stacey Young-McCaughan
Journal:  World J Urol       Date:  2011-12-24       Impact factor: 4.226

2.  Clarifying the positive association between education and prostate cancer: a Monte Carlo simulation approach.

Authors:  Tetyana Pudrovska; Andriy Anishkin
Journal:  J Appl Gerontol       Date:  2013-03-21

3.  Dysregulation of cholesterol homeostasis in human prostate cancer through loss of ABCA1.

Authors:  Byron H Lee; Margaret G Taylor; Peggy Robinet; Jonathan D Smith; Jessica Schweitzer; Ephraim Sehayek; Sara M Falzarano; Cristina Magi-Galluzzi; Eric A Klein; Angela H Ting
Journal:  Cancer Res       Date:  2012-12-11       Impact factor: 12.701

4.  Statin Use, Serum Lipids, and Prostate Inflammation in Men with a Negative Prostate Biopsy: Results from the REDUCE Trial.

Authors:  Emma H Allott; Lauren E Howard; Adriana C Vidal; Daniel M Moreira; Ramiro Castro-Santamaria; Gerald L Andriole; Stephen J Freedland
Journal:  Cancer Prev Res (Phila)       Date:  2017-05-09

Review 5.  Cholesterol and benign prostate disease.

Authors:  Michael R Freeman; Keith R Solomon
Journal:  Differentiation       Date:  2011-08-20       Impact factor: 3.880

6.  Decision preparation, satisfaction and regret in a multi-center sample of men with newly diagnosed localized prostate cancer.

Authors:  Donna L Berry; Qian Wang; Barbara Halpenny; Fangxin Hong
Journal:  Patient Educ Couns       Date:  2012-05-17

Review 7.  Cholesterol and prostate cancer.

Authors:  Kristine Pelton; Michael R Freeman; Keith R Solomon
Journal:  Curr Opin Pharmacol       Date:  2012-07-21       Impact factor: 5.547

Review 8.  Obesity and cancer: mechanistic insights from transdisciplinary studies.

Authors:  Emma H Allott; Stephen D Hursting
Journal:  Endocr Relat Cancer       Date:  2015-09-15       Impact factor: 5.678

9.  Shared common variants in prostate cancer and blood lipids.

Authors:  Ole A Andreassen; Verena Zuber; Wesley K Thompson; Andrew J Schork; Francesco Bettella; Srdjan Djurovic; Rahul S Desikan; Ian G Mills; Anders M Dale
Journal:  Int J Epidemiol       Date:  2014-04-30       Impact factor: 7.196

Review 10.  The complex interplay between cholesterol and prostate malignancy.

Authors:  Keith R Solomon; Michael R Freeman
Journal:  Urol Clin North Am       Date:  2011-06-22       Impact factor: 2.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.